Rajendran Bhaskaran, Takeda
Rajendran Bhaskaran, Sr. Director, Corporate Strategy Organization, Takeda Pharmaceuticals
Raj is with the corporate strategy organization of Takeda. With an unique blend of human capital, organization development & commercial strategy development experience, Raj focusses on designing, innovating & sustaining deliberate practices to blunt competition. Passionate about pioneering organization readiness, development & effectiveness, transformation programs around M&A contexts, Raj has enabled several organization centric transformations within the commercial / insights space, aimed at adopting an evidence based approach to decision making. With a penchant for competition centric change management, Raj believes competitive intelligence frameworks when applied to human capital related contexts could bring about transformative change, allows for experimentation with differentiated talent models, and enables a culture of engagement, agility and innovation. A firm believer in evidence based insights; Raj was responsible for defining and executing the human capital play for the global insights organization in Takeda, besides leading global competitive intelligence efforts.
Prior to Takeda, Raj has nearly a decade of experience in management consulting industry working for firms such as Frost & Sullivan, Deloitte and IMS Consulting. He was responsible for delivering organization development, commercial strategy & excellence, intelligence assignments to multinational clientele across science (pharma/healthcare), technology and consumer businesses across APAC /Emerging Markets & U.S. Raj holds a chemical engineering & MBA degree and is based in Singapore.
Ana Cerdeira, Takeda Pharmaceuticals
Ana Cerdeira, VP, Strategy, Takeda Pharmaceuticals
Ana Cerdeira is the VP of the EM Portfolio Management leading a team responsible for the portfolio prioritization, preparing the EM for Launching Takeda’s innovative Brands and giving Brand Support to the EM. Her team is also responsible for Digital Marketing and Pricing and Market Access for EM and Access to Medicines globally. Before moving to Singapore, Ana lived and worked 10 years in Switzerland, first at Janssen Pharmaceuticals as a CMC Drug Product Technical Integrator for biologics and then at Takeda in Business Development.
She has a Ph.D. from ETH Zurich in Pharmaceutical Sciences.
Anne Chi, SAI Asia
Anne Chi, President, SAI Asia
Ms. Chi has 26 years of professional consulting and operational experience in the pharmaceutical and medical device and equipment industry in Asia, with a focus on Greater China.
In late 90’s She was the General Manager of a Sino-Taiwanese medical devices Joint Venture responsible for the set up of the JV and its operation and sales in China. Ms. Chi also has been leading the Asia Operation of SAI MedPartners in the past 16 years and serving top-tier multinational pharmaceutical and medical devices company clients.
Ms. Chi is one of the few Professionals that have over 20 years of experience in competitive intelligence and intelligence-based strategy consulting, advising clients in strategies related to competition, market access, commercial and launch excellence and M&A/licensing.
Xuan Cui, Sanofi China
Xuan Cui, Head, Strategic Policy & Access, Sanofi China
Laiza Filart, A. Menarini Asia-Pacific
Laiza Filart, Regional Director, New Product Marketing and Business Intelligence, A. Menarini Asia-Pacific
Laiza Filart is the Regional Director for APAC, Business Intelligence and New Product Planning where she leads the market intelligence team that is responsible for management of primary market research projects and transformation of key findings into actionable insights going into the marketing plans, and market analytics, acquisition and maintenance of secondary
data and industry reports
Laiza previously worked at Merck Sharp and Dohme as an Associate Director of Marketing for the Vaccines and Women’s Health Business Unit.
Kazumi Fujikawa, Takeda Pharmaceuticals
Kazumi Fujikawa, VP, Market Data Management, Global Commercial, Takeda Pharmaceuticals (Japan)
Kazumi is well known in the “Insights professional circle” for her distinguished experience that includes global, regional and local roles for various multinational corporations: Pfizer, IMS, Sanofi-Aventis and has covered a range of responsibilities in her previous life that includes Product commercialization Strategy, Market Research and Analytic to logistics.
She holds BA of English Literature, Nortre Dame Seishin University, Japan and holds MBA, Marketing from Leicester University, UK. She is certified, leadership and organization development from New York University and is certified of MBTI instructor from American Management Association.
She is a key contributor of creating Steering Committee of Japan Market Research Association. She has several publications related to market research and pharmaceutical marketing.
Carlos Hernandez, Abbott Laboratories
Carlos Hernandez, Head of Market Insights, Abbott Laboratories
Carlos Hernandez is Head of Market Insights for the Global Marketing Organization at Abbott covering Singapore, China and Vietnam. Carlos has 15+ years of experience in consumer and market insights having worked with some of the FMCG leading names from both agency and industry sectors: Nielsen, Kantar, Sainsbury’s and Reckitt Benckiser. Carlos is originally from Portugal but lived most of his life in the UK. He and his family relocated to Singapore 2 ½ years ago.
Margaret Hsiao, Harvest Moon Pharmaceuticals
Margaret Hsiao, CEO & Co-Founder, Harvest Moon Pharmaceuticals
Margaret Hsiao has over 20 years of technical and commercial experience in the Rx and OTC pharmaceutical industry for both the branded and generic drug space. Harvest Moon Pharma product focus include biosimilars, high barrier to entry pharmaceuticals, and drug products for the emerging markets.
Sundeep Lal, Medtronic
Sundeep Lal, Vice President, Business Development, Strategy and Healthcare Solutions, Asia Pacific, Medtronic (Singapore)
Dr. Sundeep Lal is Vice President of Strategy, Business Development and Business Model Innovation for Medtronic. Sundeep has over twenty years of healthcare experience in pharmaceutical, bio-tech and med-tech industries in US and Emerging Markets. At Medtronic, Sundeep collaborates with Asian regional and country leaders and teams to create country specific organic and inorganic growth strategies and their execution plans. Passionate about creating innovative healthcare delivery models for solving affordability, access and awareness barriers in Emerging Markets, Sundeep is building Medtronic’s Global Business Model Innovation and “Solution and Services” capabilities to address such market specific challenges.
Prior to Medtronic, Sundeep was with Merck based out of Whitehouse Station, NJ. In eleven years with Merck, Sundeep utilized strategic insights to create transformational growth platforms through business development such as acquisition of Schering-Plough (Global), Sun and Simcere Pharma JV’s (Emerging Markets and China) and numerous early and late stage global R&D in-licensing programs. Sundeep’s last role at Merck was as Executive Director and Head of Business Development for Emerging Markets, where he was the key architect of Merck’s strategy for expansion into EM’s through differentiated BGx’s.
A Cornell MBA, Sundeep’s, prior background includes role as a management consultant as well a discovery research scientist. Sundeep has a Ph.D. in Chemistry from University of Louisville where he was a University Fellow and a B.Sc. (Honors) from University of Delhi, India. Sundeep’s work has led to start up of one biotech company, 1 patent and over 15 refereed publications. Most recently, his work has been profiled in HBR and Forbes. Sundeep serves on the board of International Partnership for Innovative Healthcare Delivery, Investment Committee Observer for Quadria Capital and an invitee to Evaluation Panel for Singapore Govt’s startup investments. Sundeep has working and living experiences in US and Asia.
Ju Hyoung Lim, Deallus Consulting
Ju Hyoung Lim, MSc, Ph.D., Senior Manager, JAPAC Operations, Deallus Consulting
Ju Hyoung is Senior Manager at Deallus, currently based in Singapore. He has years of extensive experience in the Asian pharmaceutical market, leading a number of successful partnerships with various focus on Asian pharma landscape, market access and entry strategy, competitor strategy and commercial impact assessment. His TA experience includes primary care (diabetes, GI, CV), specialty care (oncology, immunology, rare disease) as well as acute care. Ju Hyoung has written a few white paper and articles on the rapidly changing Asian pharma market, and also has presented as a keynote speaker and an expert panel in a few renowned conferences in the past years. He earned a PhD in Biological Sciences from Korea Advanced Institute of Science and Technology (KAIST) and completed a postdoctoral fellowship at Massachusetts Institute of Technology (MIT).
Nobuo Murakami, Daiichi Sankyo
Nobuo Murakami, Senior Director, Daiichi Sankyo
Noriko Nishi, Shionogi & Co.
Noriko Nishi, Vice President and Head of Global New Product Planning, Global Development, Shionogi & Co., Ltd.
Daniel Pascheles, Molekule Consulting
Daniel Pascheles, CEO, Molekule Consulting
Dr. Daniel R. Pascheles is CEO of Molekule Consulting. Pascheles was formerly Head of Global Intelligence at Merck & Co., Inc., which he joined early 2005 from Aventis Inc. where he was Vice President and head of Corporate Competitive Intelligence. He has worked for Aventis and its predecessor company (Hoechst Marion Roussel, Marion Merrell Dow) for 14 years in various positions and locations.
Pascheles studied Pharmacy at the Swiss Federal Institute of Technology in Zurich, Switzerland. He received his Ph.D. in Pharmaceutical Technology from the same university. He has done additional study at the University of Kansas in Lawrence, Kansas.
Pascheles is Past-President and current Board member of the Pharmaceutical Business Intelligence & Research Group (PBIRG). He is also member of the Society of Competitive Intelligence Professionals (SCIP) and the Licensing Executive Society (LES).
Pascal Qian, Novartis
Pascal Qian, Executive Director, Head of Solid Tumors, Novartis (China)
Steven Robery, Lifescience Dynamics
Steven Robery, BSc, Ph.D., Senior Consultant, Lifescience Dynamics
Steve is based in the London office as a Senior Consultant. He is involved in all three practice areas with a particular emphasis on CI, conference coverage and competitive simulations. He is experienced across various therapeutic areas including rheumatology, respiratory, neurology, rare diseases and biosimilars. As part of his experience, Steve has covered multiple disease related congresses, collecting primary intelligence, capturing sessions, analysis, synthesis and drawing implications. As a Senior Consultant at Lifescience Dynamics, he is predominantly involved in project management and is also part of a team committed to helping develop high impact and executable strategies for clients globally. Furthermore, he is also a full member of the client engagement team.
Steve has previously spent a year working with AstraZeneca’s R&D team, specialising in COPD. He holds a PhD in molecular biology from Royal Holloway University London, where he investigated potential novel mechanisms involved in bitter taste perception. Steve also holds a BSc in Medical Sciences from the University of Leeds.
Outside of work, Steve enjoys getting out of the country and travelling to new places, trying different foods and taking part in sports.
Neal Somchand, Deallus Consulting
Neal Somchand, MSc, Principal, JAPAC Operations, Deallus Consulting
Neal is a Principal in the Deallus Tokyo office, joining Deallus in January 2016. Neal brings with him over 8 years of experience as a consultant for medical device and pharmaceutical companies. Neal has managed projects across various geographies – concentrating on Japan and EU5 (UK, France, Germany, Spain, Italy) from a pricing and reimbursement perspective. Prior to joining Deallus, Neal spent 5 years working at the LEK Tokyo office as an Associate Consultant, focusing exclusively on the Japan market assessments and market entry strategy. More recently, Neal worked in London on EU-5 pricing and market access assessments, delivering recommendations for EU launches. Neal presented at Market Access Asia last year discussing the evolution of managed-entry agreements and pricing plans for high-priced drugs. Neal holds a Masters in Oncology from University of Nottingham, UK, and is a fluent speaker of Japanese and English.
Veena Swaminathan, Sanofi Genzyme
Veena Swaminathan, Integrated Solutions and Stakeholders Insights Lead, Sanofi Genzyme
Veena has over 13 years of experience in pharmaceutical and technology sector. She combines both industry and management consulting experience where she advised global pharmaceutical and healthcare clients.
Veena completed her MBA from INSEAD, France and Bachelor of Computer Engineering from NTU, Singapore. She loves teaching and has been a mentor for start-ups in the online education and web-technology space.
Veronique Toully, UCB
Veronique Toully, Managing Director, China, UCB (China)
Shawn Xie, Lifescience Dynamics
Shawn Xie, Senior Business Analyst, Lifescience Dynamics
Shawn is an analyst based in the US San Francisco bay area.
He is experienced in CI monitoring and competitive workshop projects across many therapeutic areas, including medical devices, immunology, oncology, ophthalmology, vaccines, and cardiovascular and rare diseases.
Shawn has previous experience at early-stage biotech and medical device firms in the US, spanning market assessment, competitive analysis, patents and licensing.
He has a strong background in biomaterials and nanotechnology with experience in nanoparticle design for gene delivery and localized cancer therapy.
Shawn holds a PhD/BS in Biomedical (or Bio-) Engineering from Stony Brook / Johns Hopkins University and is bilingual in English and Chinese (Mandarin).
Outside of work, Shawn is a health and fitness enthusiast. He is also an avid basketball fan and food lover.
Yan Zhang, Roche
Yan Zhang, Vice President, Strategic Planning and Commercial Excellence, Roche (China)
Yan started and has been with Genentech for 13 years and held various leadership roles in Forecasting & Business Analysis and Market Planning. From January 2013, she takes on new role in Roche Shanghai to lead six functional teams including Sales Force Effectiveness, Commercial Training & Development, Strategic Planning, Program Management, e-Marketing, and Event Operation Team. Prior to Genentech, she worked at McKinsey & Company and conducted drug discovery research at Syntex Pharmaceutical. She holds Bachelor’s degree from Peking University and her Ph.D. in Bio-physical Chemistry from Stanford University.
Hanson Zheng, Bristol Myers Squibb
Hanson Zheng, Director, Customer Insights & Analytics, Bristol Myers Squibb